Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-30 · accession 0001437749-23-029784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-01 | 2023-10-30 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $0.18 | +165.0K | 286.8K | +135% | +$29.7K |
| D | 2023-11-01 | 2023-10-30 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | — | +165.0K | 204.6K | +417% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-30 | P | A | 165,000 | $0.18 | 286,827 | D | — | — | (F1) Holdings do not include options to purchase 39,584 shares and warrants to purchase 165,000 shares. |
| 2 | Derivative | Warrant | 2023-10-30 | P | A | 165,000 | — | 204,584 | D | $0.18 · 2023-10-31 to 2028-10-30 | 165,000 common stock | (F2) Warrants were purchased as part of a unit with each unit consisting of one share of common stock and one warrant at a purchase price of $0.175 per unit. |